Alex De Winter

Alex is a Managing Director based in Boston and joined the team in 2013. Alex led investments in Labcyte, RainDance Technologies, Syapse, and Veracyte. He is focused on funding healthcare startups and helps build relationships between GE and innovation ecosystems on the East Coast. His portfolio spans precision medicine startups, including clinical diagnostics, life science instrumentation, bioprocessing, and data analytics. Prior to joining GE, Alex was a Partner at Mohr Davidow Ventures, specializing in healthcare and life sciences startups. Before Mohr Davidow, he was a Senior Scientist at Pacific Biosciences, working on systems integration for their Single Molecule Real Time DNA sequencing technology. Alex started his career as a scientist at 454 Life Sciences, where he worked on sample preparation and emulsion PCR for what became the first of the next-generation DNA sequencers. Alex has a PhD in Chemistry from Stanford University, an MBA from UC Berkeley, and degrees in English and Chemistry from Amherst College. He is a board observer at Labcyte, Nuvolo, and Syapse. Outside of work, Alex fancies himself an amateur lumberjack and enjoys gonzo cooking.